Imam, Hamin M.
HRN: 26-40-39 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2024
CO-AMOXICLAV 625MG (TAB)
12/19/2024
12/26/2024
PO
625mg
TID
Multiple STI
Waiting Final Action